Catalyzing precision: unraveling the diagnostic conundrum of tunisian familial hypophosphatasia case through integrative clinical and molecular approaches.
ALPL
Hypophosphatasia
In silico Analysis
Mutations
Journal
Molecular genetics and genomics : MGG
ISSN: 1617-4623
Titre abrégé: Mol Genet Genomics
Pays: Germany
ID NLM: 101093320
Informations de publication
Date de publication:
23 Jun 2024
23 Jun 2024
Historique:
received:
09
02
2024
accepted:
13
06
2024
medline:
23
6
2024
pubmed:
23
6
2024
entrez:
23
6
2024
Statut:
epublish
Résumé
Familial Hypophosphatasia presents a complex diagnostic challenge due to its wide-ranging clinical manifestations and genetic heterogeneity. This study aims to elucidate the molecular underpinnings of familial Hypophosphatasia within a Tunisian family harboring a rare c.896 T > C mutation in the ALPL gene, offering insights into genotype-phenotype correlations and potential therapeutic avenues. The study employs a comprehensive approach, integrating biochemical examination, genetic analysis, structural modeling, and functional insights to unravel the impact of this rare mutation. Genetic investigation revealed the presence of the p.Leu299Pro mutation within the ALPL gene in affected family members. This mutation is strategically positioned in proximity to both the catalytic site and the metal-binding domain, suggesting potential functional consequences. Homology modeling techniques were employed to predict the 3D structure of TNSALP, providing insights into the structural context of the mutation. Our findings suggest that the mutation may induce conformational changes in the vicinity of the catalytic site and metal-binding domain, potentially affecting substrate recognition and catalytic efficiency. Molecular dynamics simulations were instrumental in elucidating the dynamic behavior of the tissue-nonspecific alkaline phosphatase isozyme (TNSALP) in the presence of the p.Leu299Pro mutation. The simulations indicated alterations in structural flexibility near the mutation site, with potential ramifications for the enzyme's overall stability and function. These dynamic changes may influence the catalytic efficiency of TNSALP, shedding light on the molecular underpinnings of the observed clinical manifestations within the Tunisian family. The clinical presentation of affected individuals highlighted significant phenotypic heterogeneity, underscoring the complex genotype-phenotype correlations in familial Hypophosphatasia. Variability in age of onset, severity of symptoms, and radiographic features was observed, emphasizing the need for a nuanced understanding of the clinical spectrum associated with the p.Leu299Pro mutation. This study advances our understanding of familial Hypophosphatasia by delineating the molecular consequences of the p.Leu299Pro mutation in the ALPL gene. By integrating genetic, structural, and clinical analyses, we provide insights into disease pathogenesis and lay the groundwork for personalized therapeutic strategies tailored to specific genetic profiles. Our findings underscore the importance of comprehensive genetic and clinical evaluation in guiding precision medicine approaches for familial Hypophosphatasia.
Identifiants
pubmed: 38909345
doi: 10.1007/s00438-024-02157-y
pii: 10.1007/s00438-024-02157-y
doi:
Substances chimiques
ALPL protein, human
EC 3.1.3.1
Alkaline Phosphatase
EC 3.1.3.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
64Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Baroncelli GI, Carlucci G, Freri E, Giuca MR, Guarnieri V, Navarra G, Toschi B, Mora S (2023) The diagnosis of hypophosphatasia in children as a multidisciplinary effort: an expert opinion. J Endocrinol Invest. https://doi.org/10.1007/s40618-023-02199-w
doi: 10.1007/s40618-023-02199-w
pubmed: 37991698
pmcid: 10965647
Bossi M, Hoylaerts MF, Millán JL (1993) Modifications in a flexible surface loop modulate the isozyme-specific properties of mammalian alkaline phosphatases. J Biol Chem 268(34):25409–25416
doi: 10.1016/S0021-9258(19)74407-X
pubmed: 8244974
Brun-Heath I, Taillandier A, Serre JL, Mornet E (2005) Characterization of 11 novel mutations in the tissue non-specific alkaline phosphatase gene responsible for hypophosphatasia and genotype-phenotype correlations. Mol Genet Metab 84(3):273–277. https://doi.org/10.1016/j.ymgme.2004.11.003 . (Epub 2004 Dec 19 PMID: 15694177)
doi: 10.1016/j.ymgme.2004.11.003
pubmed: 15694177
Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714–2723. https://doi.org/10.1002/elps.1150181505
doi: 10.1002/elps.1150181505
pubmed: 9504803
Hypophosphatasia FD (1957) Am J Med 22(5):730–746. https://doi.org/10.1016/0002-9343(57)90124-9
doi: 10.1016/0002-9343(57)90124-9
Jandl NM, Schmidt T, Rolvien T, Stürznickel J, Chrysostomou K, von Vopelius E, Volk AE, Schinke T, Kubisch C, Amling M, Barvencik F (2021) Genotype-phenotype associations in 72 adults with suspected ALPL-associated hypophosphatasia. Calcif Tissue Int 108(3):288–301. https://doi.org/10.1007/s00223-020-00771-7
doi: 10.1007/s00223-020-00771-7
pubmed: 33191482
Le Du MH, Stigbrand T, Taussig MJ, Menez A, Stura EA (2001) Crystal structure of alkaline phosphatase from human placenta at 1.8. A resolution Implication for a substrate specificity. J Biol Chem 276(12):9158–9165. https://doi.org/10.1074/jbc.M009250200
doi: 10.1074/jbc.M009250200
pubmed: 11124260
Liu M, Liu M, Liang X, Wu D, Li W, Su C, Cao B, Chen J, Gong C (2021) Clinical and genetic characteristics of hypophosphatasia in Chinese children. Orphanet J Rare Dis 16(1):159. https://doi.org/10.1186/s13023-021-01798-1
doi: 10.1186/s13023-021-01798-1
pubmed: 33827627
pmcid: 8028151
Mao X, Liu S, Lin Y, Chen Z, Shao Y, Yu Q, Liu H, Lu Z, Sheng H, Lu X, Huang Y, Liu L, Zeng C (2019) Two novel mutations in the ALPL gene of unrelated Chinese children with Hypophosphatasia: case reports and literature review. BMC Pediatr 19(1):456. https://doi.org/10.1186/s12887-019-1800-4
doi: 10.1186/s12887-019-1800-4
pubmed: 31760938
pmcid: 6876108
Martins L, Lessa LGF, Ali TM, Lazar M, Kim CA, Kantovitz KR, Santamaria MP, Araújo CF, Ramos CJ, Foster BL et al (2023) Childhood hypophosphatasia associated with a novel biallelic ALPL variant at the TNSALP dimer interface. Int J Mol Sci 24(1):282. https://doi.org/10.3390/ijms24010282
doi: 10.3390/ijms24010282
Millán JL, Whyte MP (2016) Alkaline phosphatase and hypophosphatasia. Calcif Tissue Int 98(4):398–416. https://doi.org/10.1007/s00223-015-0079-1
doi: 10.1007/s00223-015-0079-1
pubmed: 26590809
Mornet E (2018) Hypophosphatasia Metabolism 82:142–155. https://doi.org/10.1016/j.metabol.2017.08.013
doi: 10.1016/j.metabol.2017.08.013
pubmed: 28939177
Mornet E, Taillandier A, Peyramaure S, Kaper F, Muller F, Brenner R, Bussière P, Freisinger P, Godard J, Le Merrer M, Oury JF, Plauchu H, Puddu R, Rival JM, Superti-Furga A, Touraine RL, Serre JL, Simon-Bouy B (1998) Identification of fifteen novel mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in European patients with severe hypophosphatasia. Eur J Hum Genet 6(4):308–314. https://doi.org/10.1038/sj.ejhg.5200190
doi: 10.1038/sj.ejhg.5200190
pubmed: 9781036
Mumm S, Jones J, Finnegan P, Henthorn PS, Podgornik MN, Whyte MP (2002) Denaturing gradient gel electrophoresis analysis of the tissue nonspecific alkaline phosphatase isoenzyme gene in hypophosphatasia. Mol Genet Metab 75(2):143–153. https://doi.org/10.1006/mgme.2001.3283 . (PMID: 11855933)
doi: 10.1006/mgme.2001.3283
pubmed: 11855933
Rodrigues CH, Pires DE, Ascher DB (2018) DynaMut: predicting the impact ofmutations on protein conformation, flexibility and stability. Nucleic Acids Res 46(W1):W350–W355. https://doi.org/10.1093/nar/gky300
doi: 10.1093/nar/gky300
pubmed: 29718330
pmcid: 6031064
Schalin-Jäntti C, Mornet E, Lamminen A, Välimäki MJ (2010) Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia. J ClinEndocrinolMetab 95(12):5174–5179. https://doi.org/10.1210/jc.2010-1168 . (Epub 2010 Aug 25 PMID: 20739387)
doi: 10.1210/jc.2010-1168
Scott LJ (2016) Asfotase alfa: a review in paediatric-onset hypophosphatasia. Drugs 76(2):255–262. https://doi.org/10.1007/s40265-015-0535-2
doi: 10.1007/s40265-015-0535-2
pubmed: 26744272
Smith M, Weiss MJ, Griffin CA, Murray JC, Buetow KH, Emanuel BS, Henthorn PS, Harris H (1988) Regional assignment of the gene for human liver/bone/kidney alkaline phosphatase to chromosome 1p36.1-p34. Genomics 2(2):139–143. https://doi.org/10.1016/0888-7543(88)90095-x
doi: 10.1016/0888-7543(88)90095-x
pubmed: 3410475
Spentchian M, Merrien Y, Herasse M, Dobbie Z, Gläser D, Holder SE, Ivarsson SA, Kostiner D, Mansour S, Norman A, Roth J, Stipoljev F, Taillemite JL, van der Smagt JJ, Serre JL, Simon-Bouy B, Taillandier A, Mornet E (2003) Severe hypophosphatasia: characterization of fifteen novel mutations in the ALPL gene. Hum Mutat 22(1):105–106. https://doi.org/10.1002/humu.9159 . (PMID: 12815606)
doi: 10.1002/humu.9159
pubmed: 12815606
Su N, Zhu M, Cheng X, Xu K, Kocijan R, Zhang H (2021) Six ALPL gene variants in five children with hypophosphatasia. Ann Transl Med 9(10):888. https://doi.org/10.21037/atm-21-2096
doi: 10.21037/atm-21-2096
pubmed: 34164522
pmcid: 8184488
Taillandier A, Cozien E, Muller F, Merrien Y, Bonnin E, Fribourg C, Simon-Bouy B, Serre JL, Bieth E, Brenner R, Cordier MP, De Bie S, Fellmann F, Freisinger P, Hesse V, Hennekam RC, Josifova D, Kerzin-Storrar L, Leporrier N, Zabot MT, Mornet E (2000) Fifteen new mutations (-195C>T, L-12X, 298–2A>G, T117N, A159T, R229S, 997+2T>A, E274X, A331T, H364R, D389G, 1256delC, R433H, N461I, C472S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in patients with hypophosphatasia. Hum Mutat 15(3):293. https://doi.org/10.1002/(SICI)1098-1004(200003)15:3%3c293::AID-HUMU11%3e3.0.CO;2-Q . (PMID: 10679946)
doi: 10.1002/(SICI)1098-1004(200003)15:3<293::AID-HUMU11>3.0.CO;2-Q
pubmed: 10679946
Taillandier A, Lia-Baldini AS, Mouchard M, Robin B, Muller F, Simon-Bouy B, Serre JL, Bera-Louville A, Bonduelle M, Eckhardt J, Gaillard D, Myhre AG, Körtge-Jung S, Larget-Piet L, Malou E, Sillence D, Temple IK, Viot G, Mornet E (2001) Twelve novel mutations in the tissue-nonspecific alkaline phosphatase gene (ALPL) in patients with various forms of hypophosphatasia. Hum Mutat 18(1):83–84. https://doi.org/10.1002/humu.1154 . (PMID: 11438998)
doi: 10.1002/humu.1154
pubmed: 11438998
Tenorio J, Álvarez I, Riancho-Zarrabeitia L, Martos-Moreno GÁ, Mandrile G, de la Flor CM, Sukchev M, Sherif M, Kramer I, Darnaude-Ortiz MT, Arias P, Gordo G, Dapía I, Martinez-Villanueva J, Gómez R, Iturzaeta JM, Otaify G, García-Unzueta M, Rubinacci A, Riancho JA, Aglan M, Temtamy S, Hamid MA, Argente J, Ruiz-Pérez VL, Heath KE, Lapunzina P (2017) Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia. Am J Med Genet A 173(3):601–610. https://doi.org/10.1002/ajmg.a.37991 . (Epub 2017 Jan 27 PMID: 28127875)
doi: 10.1002/ajmg.a.37991
pubmed: 28127875
Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer FT, de Beer TAP, Rempfer C, Bordoli L, Lepore R, Schwede T (2018) SWISS-MODEL: homology modelling of protein structures and complexes. NucleicAcidsRes 46:W296–W303
doi: 10.1093/nar/gky427
Xu L, Pang Q, Jiang Y, Wang O, Li M, Xing X, Xia W (2018) Four novel mutations in the ALPL gene in Chinese patients with odonto, childhood, and adult hypophosphatasia. Biosci Rep 38:4
doi: 10.1042/BSR20171377
Yu F, Wang J, Xu X (2019) Lethal perinatal hypophosphatasia caused by a novel compound heterozygous mutation: a case report. BMC Pediatr 19(1):109. https://doi.org/10.1186/s12887-019-1478-7
doi: 10.1186/s12887-019-1478-7
pubmed: 30979366
pmcid: 6461808